Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Yale University

    Trial Locations
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Carcinoma of Urinary Tract, Urethral Carcinoma, Carcinoma of Ureter, Carcinoma of Renal Pelvis
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Connecticut Clinical Research Center, LLC
    Middlebury, Connecticut 06762
    Prostatic Neoplasms
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Women's Health Specialty Care
    Farmington, Connecticut 06032
    Overactive Bladder
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Head and Neck Cancer, Precancerous Condition
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Norwalk Hospital

    Trial Locations
    Norwalk Hospital
    Cancer Center of Central Connecticut
    Acute Myeloid Leukemia
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Grove Hill Clinical Research, Grove Hill Medical Center, Urology Center of Grove Hill

    Trial Locations
    Grove Hill Clinical Research, Grove Hill Medical Center, Urology Center of Grove Hill
    The Urology Center, PC
    Norwalk Hospital
    Eastern Connecticut Hematology and Oncology Associates
    The Stamford Hospital
    Advanced Prostate Cancer, Prostatic Neoplasms
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Prostate Cancer
    Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Castrate Resistant Prostate Cancer, Chemotherapy Naive Prostate Cancer, Prostate Cancer
    Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
    Eastern CT Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Prostate Cancer
    A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
    GSK Investigational Site
    Hartford, Connecticut 06106
    Infection, Human Immunodeficiency Virus
    Treating Low-Income Smokers in the Hospital Emergency Department
    Yale University
    New Haven, Connecticut 06520
    Tobacco Use Cessation, Smoking Cessation, Smoking, Tobacco Use Disorder
    Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel
    Investigational Site Number 840001
    New Haven, Connecticut 06510
    Ovarian Cancer Recurrent
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Recurrent Neuroblastoma
    Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1
    Yale University

    Trial Locations
    Yale University
    Yale - New Haven Hospital Nathan Smith Clinic
    Circle CARE Center
    HIV-1
    Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
    Yale School of Medicine
    New Haven, Connecticut 06510
    Glioblastoma Multiforme
    S0820, Adenoma and Second Primary Prevention Trial
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Colorectal Neoplasms
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Cyclophosphamide With or Without Veliparib in Patients With Locally Advanced or Metastatic Breast Cancer
    University of Connecticut
    Farmington, Connecticut 06032
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
    Shoreline Medical Center

    Trial Locations
    Shoreline Medical Center
    Yale University, Emergency Department
    Renal Colic, Flank Pain, Back Pain
    Phase I Biomarker Study (BMS-936558)
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Renal Cell Carcinoma
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Yale Cancer Center
    Lymphoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Non Small Cell Lung Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Praxair Cancer Center at Danbury Hospital

    Trial Locations
    Praxair Cancer Center at Danbury Hospital
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Yale Cancer Center
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    St. Vincent's Medical Center
    Bridgeport, Connecticut 06606
    Prostate Cancer
    Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Bacterial Infection, Leukemia, Musculoskeletal Complications, Neutropenia
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer